Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,059
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,786
Class I recallsReasonable probability of serious health consequences
24,313
Class II recallsTemporary or medically reversible health consequences
2,876
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/made-fresh-salads-inc-recalls-ready-eat-deli-style-salads-and-cream-cheese-because-possible-healthPublished September 6, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2

Showing 1,341–1,360 of 18,528 recalls

FDA Recall United States Terminated Historical recordClass I

My Life Inc

Product
Lactoferrin as Apolactoferrin 60 vegetarian capsules, 300 mg…
Reason
Undeclared milk allergen
Published
May 28, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Testosterone Cypionate Injection, 200 mg/mL, CIII, Rx Only, 5 mL Sterile Multiple-Dose Vial, Compounded by: Empower Pharmacy, 7601 N Sam Houston Pkwy W Ste 100, Houston, TX, 77064, Phone: (877) 562-8577, Compounding Date: 08/20/2024, Beyond Use by Date: 05/28/2025, Lot 202364.

by Empower Clinic Services, LLC dba Empower Pharmacy

Reason
Lack of Assurance of Sterility
Published
May 21, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, a) UPC 3606000508804, 20 mL (0.7 fl. oz.) Tube per Carton, b) 883140500759, 40 mL (1.35 fl. oz.) Tube per Carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, France.

by L'Oreal USA

Reason
cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.
Published
May 21, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne Routine Kit, Medicated Gel Cleanser 3.4 fl. oz. (100 mL) Tube, Clarifying Solution 3.4 fl. oz. (100 mL) Tube, Dual Action Acne Treatment 0.7 fl. oz. (20 mL: UPC 883140035275) Tube, (benzoyl peroxide 0.5% and benzoyl peroxide 5.5% and salicylic acid 2%), La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, France, UPC 883140035282 (kit).

by L'Oreal USA

Reason
cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.
Published
May 21, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.

by L'Oreal USA

Reason
Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
Published
May 21, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

TESTOSTERONE PELLET 200 mg BLUNT, 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0121-01

by BSO LLC

Reason
Presence of Particulate Matter: Glass particles were found in pellet vials.
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

TESTOSTERONE PELLET 200 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0122-01

by BSO LLC

Reason
Presence of Particulate Matter: Glass particles were found in pellet vials.
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

TESTOSTERONE PELLET 200 mg BLUNT (with Cholesterol </=2%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0124-01

by BSO LLC

Reason
Presence of Particulate Matter: Glass particles were found in pellet vials.
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

TESTOSTERONE PELLET 200 mg (with Cholesterol </=2%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0125-01

by BSO LLC

Reason
Presence of Particulate Matter: Glass particles were found in pellet vials.
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

TESTOSTERONE PELLET 100 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0101-01

by BSO LLC

Reason
Presence of Particulate Matter: Glass particles were found in pellet vials.
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

temper tamer, 1 US fl oz. (29.6 mL), Homeopathic Oral Spray, Manufactured by: Siddha Flower Essences, Oxnard, CA, 93030 NDC 69779-020-01.

by Siddha Flower Essences, LLC.

Reason
CGMP Deviations
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Polyvinyl Alcohol Ophthalmic Solution 1.4%, Lubricant Eye Drops, Moisturizing, Sterile, 0.5 FL OZ (15mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-678-15.

by BRS Analytical Services, LLC

Reason
cGMP deviations and lack of assurance of sterility.
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Lubricant Eye Drops Solution, Polyethylene Glycol 400 0.4% Eye Lubricant, Propylene Glycol 0.3% Eye Lubricant, Lubricant Eye Drops, Moisturizing, Sterile, 0.5 FL OZ (15mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-126-15.

by BRS Analytical Services, LLC

Reason
cGMP deviations and lack of assurance of sterility.
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Carboxymethlycellulose Sodium 0.5% Eye Lubricant, Lubricating Eye Drops, Moisturizing, Sterile, 0.5 FL OZ (15mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-068-15.

by BRS Analytical Services, LLC

Reason
cGMP deviations and lack of assurance of sterility.
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Carboxymethylcellulose Sodium Ophthalmic Gel 1%, Carboxymethlycellulose Sodium 1% Eye Lubricant, Lubricant Eye Gel, Soothing Gel, Sterile, 0.5 FL OZ (15mL) per bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-066-15.

by BRS Analytical Services, LLC

Reason
cGMP deviations and lack of assurance of sterility.
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Artificial Tears Ophthalmic Solution, Dextran 70.01%/Glycerin 0.2%/Hypromellose 0.3% (Eye Lubricants) Lubricant Eye Drops, STERILE, 0.5 FL OZ (15 mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-043-15.

by BRS Analytical Services, LLC

Reason
cGMP deviations and lack of assurance of sterility.
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 10mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-01.

by FDC Limited

Reason
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)

by Amneal Pharmaceuticals, LLC

Reason
Presence of Particulate Matter
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Optimal Carnivore, LLC

Product
Bone & Joint Restore. 180 capsules in a plastic bottle. Shel…
Reason
Potential for contamination with salmonella.
Published
May 14, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC carton: 0517-0735-10 / NDC Vial: 0517-0735-01]

by American Regent, Inc.

Reason
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Published
May 7, 2025
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.